Compare KAI & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KAI | ITGR |
|---|---|---|
| Founded | 1991 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 2.9B |
| IPO Year | 1996 | 2000 |
| Metric | KAI | ITGR |
|---|---|---|
| Price | $311.68 | $85.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $337.50 | $91.14 |
| AVG Volume (30 Days) | 139.3K | ★ 346.4K |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.42% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 8.65 | 2.89 |
| Revenue | $1,052,248,000.00 | ★ $1,853,637,000.00 |
| Revenue This Year | $13.28 | $1.69 |
| Revenue Next Year | $4.87 | $6.53 |
| P/E Ratio | $37.72 | ★ $29.33 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $244.87 | $62.00 |
| 52 Week High | $369.97 | $127.56 |
| Indicator | KAI | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 46.57 | 47.17 |
| Support Level | $283.46 | $82.58 |
| Resistance Level | $336.37 | $88.54 |
| Average True Range (ATR) | 11.34 | 2.20 |
| MACD | 0.69 | -0.32 |
| Stochastic Oscillator | 48.87 | 34.70 |
Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.